MENS
Jyong Biotech Ltd.
NASDAQ · Healthcare · Biotechnology · TW
$2.06
−0.96%Institutional positioning
13F filings over the trailing two quarters
New 9Increased 11Reduced 16Sold out 3
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 260,317 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 258,760 | May 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 68,882 | Aug 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 64,232 | May 15, 2026 |
| HRT FINANCIAL LP | Increased | 50,423 | Aug 14, 2026 |
| UBS GROUP AG | Reduced | 37,363 | May 5, 2026 |
| XTX Topco Ltd | New Position | 29,066 | Aug 14, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | New Position | 22,900 | Aug 13, 2026 |
| MILLENNIUM MANAGEMENT LLC | Reduced | 14,590 | May 15, 2026 |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | New Position | 13,927 | May 14, 2026 |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | Increased | 13,173 | Apr 28, 2026 |
| China Universal Asset Management Co., Ltd. | Reduced | 12,100 | Jul 24, 2026 |
| HRT FINANCIAL LP | New Position | 11,767 | May 14, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | Increased | 11,703 | May 15, 2026 |
| State of Wyoming | New Position | 11,208 | Aug 6, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings